Cited by 174Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated ReceptorsCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR

Open access

Schug, Thaddeus T., Berry, Daniel C., Toshkov, Illia A., Cheng, Le, Nikitin, Alexander Yu, Noy, Noa·2008·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0709981105PMC PMC2396692

Open this paper in CoChat — free account

Abstract

Retinoic acid (RA) displays potent anticarcinogenic activities that are mediated by the nuclear retinoic acid receptors (RARs). However, use of RA in oncology is limited by RA resistance acquired during carcinogenesis. Moreover, in some cancers, RA facilitates rather than inhibits growth. A clue to this paradoxical behavior was recently suggested by the findings that RA also activates PPARβ/δ, a receptor involved in mitogenic and anti-apoptotic activities. The observations that partitioning of RA between its two receptors is regulated by two intracellular lipid-binding proteins—CRABP-II, which targets RA to RAR, and FABP5, which delivers it to PPARβ/δ—further suggest that RA resistance may stem from the deregulation of the binding proteins, resulting in activation of PPARβ/δ rather than RAR. Here, we show that, in the RA-resistant mouse model of breast cancer MMTV-neu , RA indeed activates the nonclassical RA receptor PPARβ/δ. This behavior was traced to an aberrantly high intratumor FABP5/CRABP-II ratio. Decreasing this ratio in mammary tissue diverted RA from PPARβ/δ to RAR and suppressed tumor growth. The data demonstrate the existence of a mechanism that underlies RA resistance in tumors, indicate that CRABP-II functions as a tumor suppressor, and suggest that the inhibition of FABP5 may comprise a therapeutic strategy for overcoming RA resistance in some tumors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0709981105

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
Guy, C. T., Webster, M. A., Schaller, M. D., Parsons, T. J., Cardiff, R. D., & Muller, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Amplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
King, C. R., Kraus, M. H., & Aaronson, S. A. (1985) · Science · doi:10.1126/science.2992089 · Cited by 1,054
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Furuhashi, M., Tuncman, G., Görgün, C. Z., Makowski, L., Atsumi, G., Vaillancourt, E., Kono, K., Babaev, V. R., Fazio, S., Linton, M. F., et al. (2007) · Nature · doi:10.1038/nature05844 · Cited by 730
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
Self-citation
Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription
Tan, N.-S., Shaw, N. S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B., Wahli, W., & Noy, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5114-5127.2002 · Cited by 499
Self-citation
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L. G., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 491
Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene
Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., & Wahli, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004029200 · Cited by 489

Show all 45 references

Sorted by citations

Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function
Field, C. S., Baixauli, F., Kyle, R. L., Puleston, D. J., Cameron, A. M., Sanin, D. E., Hippen, K. L., Loschi, M. L., Thangavelu, G., Corrado, M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.021 · Cited by 443
Vitamin A and retinoid signaling: genomic and nongenomic effects
Al Tanoury, Z., Piskunov, A., & Rochette-Egly, C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r030833 · Cited by 408
Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
Itoh, Y., Ishikawa, M., Naito, M., & Hashimoto, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100691p · Cited by 404
Tissue-specific Functions in the Fatty Acid-binding Protein Family
Storch, J., & THUMSER, A. E. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.135210 · Cited by 363
All- trans -Retinoic Acid Represses Obesity and Insulin Resistance by Activating both Peroxisome Proliferation-Activated Receptor β/δ and Retinoic Acid Receptor
Berry, D. C., & Noy, N. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01742-08 · Cited by 345
Self-citation
Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer
Hua, S., Kittler, R., & White, K. P. (2009) · Cell · doi:10.1016/j.cell.2009.04.043 · Cited by 301
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Vassalli, G. (2019) · Stem Cells International · doi:10.1155/2019/3904645 · Cited by 296
Structural and functional analysis of fatty acid-binding proteins
Storch, J., & McDermott, L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800084-jlr200 · Cited by 297
Retinoic acid signaling and neuronal differentiation
Janesick, A., Wu, S. C., & Blumberg, B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1815-9 · Cited by 295
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases
Napoli, J. L. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.01.004 · Cited by 262
Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)
Rochette‐Egly, C., & Germain, P. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07005 · Cited by 263
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
Bowen, N. J., Walker, L. D., Matyunina, L. V., Logani, S., Totten, K. A., Benigno, B. B., & McDonald, J. F. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-71 · Cited by 241
Aldehyde dehydrogenases and cancer stem cells
Xu, X., Chai, S., Wang, P., Zhang, C., Yang, Y., Yang, Y., & Wang, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.018 · Cited by 209
Between Death and Survival: Retinoic Acid in Regulation of Apoptosis
Noy, N. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155509 · Cited by 192
Self-citation
Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions
Wagner, K., & Wagner, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.001 · Cited by 198
Retinoic Acid Upregulates Preadipocyte Genes to Block Adipogenesis and Suppress Diet-Induced Obesity
Berry, D. C., DeSantis, D., Soltanian, H. T., Croniger, C. M., & Noy, N. (2012) · Diabetes · doi:10.2337/db11-1620 · Cited by 180
Self-citation
Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer
Liu, R., Graham, K., Glubrecht, D. D., Germain, D. R., Mackey, J. R., & Godbout, R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.075 · Cited by 163
Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors
Falomir‐Lockhart, L. J., Cavazzutti, G. F., Giménez, E., & Toscani, A. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00162 · Cited by 164
Physiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers
Amiri, M., Yousefnia, S., Forootan, F. S., Peymani, M., Ghaedi, K., & Nasr‐Esfahani, M. H. (2018) · Gene · doi:10.1016/j.gene.2018.07.035 · Cited by 150
Retinoids and breast cancer: From basic studies to the clinic and back again
Garattini, E., Bolis, M., Garattini, S. K., Fratelli, M., Centritto, F., Paroni, G., Gianni’, M., Zanetti, A., Pagani, A., Fisher, J. N., et al. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.01.001 · Cited by 135
Structural Basis for Ligand Regulation of the Fatty Acid-binding Protein 5, Peroxisome Proliferator-activated Receptor β/δ (FABP5-PPARβ/δ) Signaling Pathway
Armstrong, E. H., Goswami, D., Griffin, P. R., Noy, N., & Ortlund, E. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.514646 · Cited by 135
Self-citation
The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5
Guaita‐Esteruelas, S., Gumà, J., Masana, L., & Borràs, J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.002 · Cited by 135
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
Marcato, P., Dean, C. A., Liu, R., Coyle, K. M., Bydoun, M., Wallace, M., Clements, D. R., Turner, C., Mathenge, E. G., Gujar, S. A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.010 · Cited by 142
Role of fatty acid binding proteins (FABPs) in cancer development and progression
McKillop, I. H., Girardi, C. A., & Thompson, K. J. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.06.001 · Cited by 132
Retinoic Acid Induces Neurogenesis by Activating Both Retinoic Acid Receptors (RARs) and Peroxisome Proliferator-activated Receptor β/δ (PPARβ/δ)
Yu, S., Levi, L., Siegel, R. E., & Noy, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410381 · Cited by 116
Self-citation
Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5
Levi, L., Wang, Z., Doud, M. K., Hazen, S. L., & Noy, N. (2015) · Nature Communications · doi:10.1038/ncomms9794 · Cited by 113
Self-citation
Genetic Ablation of the Fatty Acid–Binding Protein FABP5 Suppresses HER2-Induced Mammary Tumorigenesis
Levi, L., Lobo, G. P., Doud, M. K., Lintig, J. V., Seachrist, D. D., Tochtrop, G. P., & Noy, N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0384 · Cited by 109
Self-citation
Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth
Kannan-Thulasiraman, P., Seachrist, D. D., Mahabeleshwar, G. H., Jain, M. K., & Noy, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099770 · Cited by 100
Self-citation
Epigenetic Silencing of CRABP2 and MX1 in Head and Neck Tumors
Calmon, M. F., Rodrigues, R. V., Kaneto, C. M., de Moura, R. P., da Silva, S. D., Mota, L. D. C., Pinheiro, D. G., Torres, C., de Carvalho, A. F., Cury, P. M., et al. (2009) · Neoplasia · doi:10.1593/neo.91110 · Cited by 99
The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis
Han, S. J., & O’Malley, B. W. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu002 · Cited by 98
Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer
Peters, J. M., & Gonzalez, F. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.06.002 · Cited by 99
Functions of Intracellular Retinoid Binding-Proteins
Napoli, J. L. (2016) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-024-0945-1_2 · Cited by 95
All-trans-Retinoic Acid Ameliorates Hepatic Steatosis in Mice by a Novel Transcriptional Cascade
Kim, S. C., Kim, C., Axe, D., Cook, A., Lee, M., Li, T., Smallwood, N. D., Chiang, J. Y. L., Hardwick, J. P., Moore, D. D., et al. (2013) · Hepatology · doi:10.1002/hep.26699 · Cited by 91
Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers
Lavudi, K., Nuguri, S. M., Olverson, Z. A., Dhanabalan, A. K., Patnaik, S., & Kokkanti, R. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1254612 · Cited by 90
Development of target protein-selective degradation inducer for protein knockdown
Itoh, Y., Ishikawa, M., Kitaguchi, R., Sato, S., Naito, M., & Hashimoto, Y. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.057 · Cited by 87
Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic Gliomas
Campos, B., Centner, F.-S., Bermejo, J. L., Ali, R., Dorsch, K., Wan, F., Felsberg, J., Ahmadi, R., Grabe, N., Reifenberger, G., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.051 · Cited by 86
Involvement of Fatty Acid Binding Protein 5 and PPAR β / δ in Prostate Cancer Cell Growth
Morgan, E., Kannan-Thulasiraman, P., & Noy, N. (2010) · PPAR Research · doi:10.1155/2010/234629 · Cited by 85
Self-citation
Integrative and Systemic Approaches for Evaluating PPARβ/δ (PPARD) Function
Attianese, G. M. P. G., & Desvergne, B. (2015) · Nuclear Receptor Signaling · doi:10.1621/nrs.13001 · Cited by 88
A Comprehensive Nuclear Receptor Network for Breast Cancer Cells
Kittler, R., Zhou, J. H. S., Hua, S., Ma, L., Liu, Y., Pendleton, E., Cheng, C., Gerstein, M., & White, K. P. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.004 · Cited by 81
Establishing the Role of PPARβ/δ in Carcinogenesis
Peters, J. M., Gonzalez, F. J., & Müller, R. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.004 · Cited by 81
Fatty acid‐binding protein 5 function in hepatocellular carcinoma through induction of epithelial–mesenchymal transition
Ohata, T., Yokoo, H., Kamiyama, T., Fukai, M., Aiyama, T., Hatanaka, Y., Hatanaka, K. C., Wakayama, K., Orimo, T., Kakisaka, T., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1020 · Cited by 78
Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
Xia, J. L., Li, S., Liu, S., & Zhang, L. (2023) · MedComm · doi:10.1002/mco2.195 · Cited by 80
Altered retinoid uptake and action contributes to cell survival in endometriosis
Pavone, M. E., Reierstad, S., Sun, H., Milad, M., Bulun, S. E., & Cheng, Y.-H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0459 · Cited by 74
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Tan, N. S., Vázquez‐Carrera, M., Montagner, A., Sng, M. K., Guillou, H., & Wahli, W. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.001 · Cited by 75
Retinoic Acids in the Treatment of Most Lethal Solid Cancers
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020360 · Cited by 74
CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid
Liu, R., Garcia, E., Glubrecht, D. D., Poon, H. Y., Mackey, J. R., & Godbout, R. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0380-7 · Cited by 72
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
Thulasiraman, P., McAndrews, D. J., & Mohiuddin, I. Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-724 · Cited by 69
A fatty acid‐binding protein 7/RXRβ pathway enhances survival and proliferation in triple‐negative breast cancer
Liu, R., Graham, K., Glubrecht, D. D., Lai, R. L., Mackey, J. R., & Godbout, R. (2012) · The Journal of Pathology · doi:10.1002/path.4001 · Cited by 69
Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Gupta, S., Pramanik, D., Mukherjee, R., Campbell, N. R., Elumalai, S., de Wilde, R. F., Hong, S., Goggins, M., Jesus‐Acosta, A. D., Laheru, D. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2165 · Cited by 68
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
Eriksson, P., Aine, M., Veerla, S., Liedberg, F., Sjödahl, G., & Höglund, M. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0101-5 · Cited by 67
Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
Dobrotkova, V., Chlapek, P., Mazánek, P., Štěrba, J., & Veselská, R. (2018) · BMC Cancer · doi:10.1186/s12885-018-4966-5 · Cited by 67
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
Wagner, N., & Wagner, K. (2022) · Cells · doi:10.3390/cells11152432 · Cited by 69
Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy
Ma, Z., Yu, J. H., Yu, Y., & Liang, D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113247 · Cited by 63
Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
Bhat‐Nakshatri, P., Goswami, C. P., Badve, S., Sledge, G. W., & Nakshatri, H. (2013) · Scientific Reports · doi:10.1038/srep02530 · Cited by 65
Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses
Yu, D. C. W., Liang, X., Lipsky, S., Karaaslan, Ç., Kozakewich, H. P., Hotamışlıgil, G. S., Bischoff, J. E., & Çataltepe, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9491-4 · Cited by 62
Enzymatic Metabolism of Vitamin A in Developing Vertebrate Embryos
Metzler, M. A., & Sandell, L. J. (2016) · Nutrients · doi:10.3390/nu8120812 · Cited by 65
Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis
Peters, J. M., Foreman, J. E., & Gonzalez, F. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9320-1 · Cited by 64
Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPAR-β/δ) Inhibits Human Breast Cancer Cell Line Tumorigenicity
Yao, P., Morales, J. L., Zhu, B., Kang, B.-H., Gonzalez, F. J., & Peters, J. M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0836 · Cited by 61
FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway
Lv, Q., Wang, G., Zhang, Y., Han, X., Li, H., Le, W., Zhang, M., Ma, C., Wang, P., & Ding, Q. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4721 · Cited by 61
Nuclear Translocation of Cellular Retinoic Acid-binding Protein II Is Regulated by Retinoic Acid-controlled SUMOylation
Majumdar, A., Petrescu, A. D., Xiong, Y., & Noy, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.293464 · Cited by 60
Self-citation
Role of the Molybdoflavoenzyme Aldehyde Oxidase Homolog 2 in the Biosynthesis of Retinoic Acid: Generation and Characterization of a Knockout Mouse
Terao, M., Kurosaki, M., Barzago, M. M., Fratelli, M., Bagnati, R., Bastone, A., Giudice, C., Scanziani, E., Mancuso, A., Tiveron, C., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01385-08 · Cited by 60
Src is activated by the nuclear receptor peroxisome proliferator‐activated receptor β/δ in ultraviolet radiation‐induced skin cancer
Montagner, A., Delgado, M. B., Tallichet-Blanc, C., Chan, J. S. K., Sng, M. K., Mottaz, H., Degueurce, G., Lippi, Y., Moret, C., Baruchet, M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302666 · Cited by 60
Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer
Apaya, M. K., Hsiao, P., Yang, Y., & Shyur, L. (2020) · Cancers · doi:10.3390/cancers12010199 · Cited by 60
Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action
Pavone, M. E., Dyson, M., Reirstad, S., Pearson, E., Ishikawa, H., Cheng, Y. H., & Bulun, S. E. (2011) · Human Reproduction · doi:10.1093/humrep/der172 · Cited by 56
Repression of Cellular Retinoic Acid-binding Protein II during Adipocyte Differentiation
Berry, D. C., Soltanian, H. T., & Noy, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110635 · Cited by 55
Self-citation
Transcript Stabilization by the RNA-Binding Protein HuR Is Regulated by Cellular Retinoic Acid-Binding Protein 2
Vreeland, A. C., Yu, S., Levi, L., Rossetto, D. D. B., & Noy, N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00281-14 · Cited by 54
Self-citation
Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma
Liu, R., Li, S., Garcia, E., Glubrecht, D. D., Poon, H. Y., Easaw, J. C., & Godbout, R. (2016) · Glia · doi:10.1002/glia.22976 · Cited by 55
The Role of PPARs in Breast Cancer
Zhao, B., Xin, Z., Ren, P., & Wu, H. (2022) · Cells · doi:10.3390/cells12010130 · Cited by 53
Cellular Retinoic Acid-binding Protein 2 Inhibits Tumor Growth by Two Distinct Mechanisms
Vreeland, A. C., Levi, L., Zhang, W., Berry, D. C., & Noy, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.604041 · Cited by 48
Self-citation
Nuclear and extranuclear effects of vitamin A
Iskakova, M., Karbyshev, M. S., Piskunov, A., & Rochette‐Egly, C. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0522 · Cited by 47
Physiological and pathological implications of retinoid action in the endometrium
Jiang, Y., Chen, L., Taylor, R. N., Li, C., & Zhou, X. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0544 · Cited by 52
Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling
Zhang, W., Levi, L., Banerjee, P., Jain, M. K., & Noy, N. (2015) · Oncotarget · doi:10.18632/oncotarget.5767 · Cited by 42
Self-citation
CRABP‐II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells
Yuan-Shan, F., Wang, Q. Q., Ma, J., Yang, X., Wu, M., Zhang, K., Kong, Q., Chen, X.-Y., Sun, Y., Chen, N., et al. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.11.004 · Cited by 41
The one-two punch
Noy, N. (2013) · Adipocyte · doi:10.4161/adip.23489 · Cited by 40
Self-citation
Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients
Guaita‐Esteruelas, S., Saavedra-García, P., Bosquet, A., Borràs, J., Girona, J., Amiliano, K., Rodríguez-Balada, M., Heras, M., Masana, L., & Gumà, J. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0483 · Cited by 41
Chemical Protein Degradation Approach and its Application to Epigenetic Targets
Itoh, Y. (2018) · The Chemical Record · doi:10.1002/tcr.201800032 · Cited by 41
FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma
Wu, G., Xu, Y., Wang, Q., Li, J., Li, L., Han, C., & Xia, Q. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172637 · Cited by 39
Analysis of Common and Specific Mechanisms of Liver Function Affected by Nitrotoluene Compounds
Deng, Y., Meyer, S. A., Guan, X., Escalon, B. L., Ai, J., Wilbanks, M. S., Welti, R., García‐Reyero, N., & Perkins, E. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014662 · Cited by 40
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
Coyle, K. M., Maxwell, S. P., Thomas, M. L., & Marcato, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-16687-6 · Cited by 38
Disparate roles of retinoid acid signaling molecules in kidney disease
Chen, A., Liu, Y., Lu, Y., Lee, K., & He, C. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00045.2021 · Cited by 38
Ovariectomy and 17β-estradiol alter transcription of lipid metabolism genes and proportions of neo-formed n-3 and n-6 long-chain polyunsaturated fatty acids differently in brain and liver
Alessandri, J., Extier, A., Al-Gubory, K. H., Goustard, B., Baudry, C., LePoupon, C., Lavialle, M., & Guesnet, P. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.005 · Cited by 40
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer
Garattini, E., Bolis, M., Gianni’, M., Paroni, G., Fratelli, M., & Terao, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7410 · Cited by 36
Peroxisomal Fatty Acid Oxidation and Glycolysis Are Triggered in Mouse Models of Lesional Atopic Dermatitis
Pavel, P., Leman, G., Hermann, M., Ploner, C., Eichmann, T. O., Minzaghi, D., Radner, F. P. W., Frari, B. D., Gruber, R. W., & Dubrac, S. (2021) · JID Innovations · doi:10.1016/j.xjidi.2021.100033 · Cited by 35
Nuclear and Extra-Nuclear Effects of Retinoid Acid Receptors: How They Are Interconnected
Piskunov, A., Tanoury, Z. A., & Rochette‐Egly, C. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9050-5_6 · Cited by 38
Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor
Yang, Q., Wang, R., Xiao, W., Sun, F., Yuan, H., & Pan, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148381 · Cited by 34
CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases
Nhieu, J., Lin, Y., & Wei, L. (2022) · Nutrients · doi:10.3390/nu14071528 · Cited by 34
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer
Fernando, W., Cruickshank, B. M., Arun, R. P., MacLean, M. R., Cahill, H. F., Morales-Quintanilla, F., Dean, C. A., Wasson, M. D., Dahn, M. L., Coyle, K. M., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03156-4 · Cited by 32
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia
Conserva, M. R., Anelli, L., Zagaria, A., Specchia, G., & Albano, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122921 · Cited by 31
17q12-21 – The pursuit of targeted therapy in breast cancer
Glynn, R. W., Miller, N., & Kerin, M. J. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.12.007 · Cited by 31
Nuclear receptor peroxisome proliferator activated receptor (PPAR) β/δ in skin wound healing and cancer
Montagner, A., Wahli, W., & Tan, N. S. (2015) · European Journal of Dermatology · doi:10.1684/ejd.2014.2505 · Cited by 30
An Amplified Fatty Acid-Binding Protein Gene Cluster in Prostate Cancer: Emerging Roles in Lipid Metabolism and Metastasis
Liu, R., & Godbout, R. (2020) · Cancers · doi:10.3390/cancers12123823 · Cited by 29
RNA-binding protein HuR regulates nuclear import of protein
Zhang, W., Vreeland, A. C., & Noy, N. (2016) · Journal of Cell Science · doi:10.1242/jcs.192096 · Cited by 28
Self-citation
MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro
Fischer-Huchzermeyer, S., Dombrowski, A., Wilke, G., Stahn, V., Streubel, A., Mautner, V. F., & Harder, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187700 · Cited by 28
DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid
Coyle, K. M., Dean, C. A., Thomas, M. L., Vidovic, D., Giacomantonio, C. A., Helyer, L. K., & Marcato, P. (2018) · Cancers · doi:10.3390/cancers10110397 · Cited by 27
Redox regulation by carotenoids: Evidence and conflicts for their application in cancer
Russo, G. L., Moccia, S., Russo, M., & Spagnuolo, C. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114838 · Cited by 27
Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study
Chen, X., Peng, R., Peng, D., Liu, D., & Li, R. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05506-y · Cited by 26
Tretinoin-loaded lipid-core nanocapsules overcome the triple-negative breast cancer cell resistance to tretinoin and show synergistic effect on cytotoxicity induced by doxorubicin and 5-fluororacil
Schultze, E., Buss, J. H., Coradini, K., Begnini, K. R., Guterres, S. S., Collares, T. V., Beck, R. C. R., Pohlmann, A. R., & Seixas, F. K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.020 · Cited by 26
CRABP‐II‐ and FABP5‐independent all‐trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells
Chen, N., Li, Y., Wu, M., Liu, Z., Fu, Y., Kong, Q., Chen, X., Li, H., & Liu, J. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01392.x · Cited by 25

Authors: Schug, T. T., Berry, D. C., Toshkov, I. A., Cheng, L., Nikitin, A. Y., & Noy, N.
Affiliations: Cornell University (US)
Case Western Reserve University (US)
ORCID: Berry, Daniel C.
Nikitin, Alexander Yu
Noy, Noa
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2008-05-27
Volume: 105
Issue: 21
Pages: 7546-7551
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0709981105
PMC: PMC2396692
OpenAlex: W2093995222
Cited by: 172
References: 45
Citations by year: 2026: 1 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 12 · 2016: 12 · 2015: 15 · 2014: 15 · 2013: 10 · 2012: 7
FWCI: 5.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (CA107013)
National Cancer Institute (R01CA096823, R01 CA 96823, R01CA107013, T32CA009682)
National Center for Research Resources (CA96823, K26RR017595)
Institute of Genetics
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: retinoic acid resistance, PPARδ, retinoic acid receptor, breast cancer, FABP5, CRABP2, lipid-binding proteins, tumor suppressor, retinoic acid signaling, breast cancer treatment
MeSH terms: Animals, Antineoplastic Agents, Carcinoma, Disease Models, Animal, Mice, Transgenic, Neoplasm Proteins, Transcription, Genetic, Tretinoin, Mammary Neoplasms, Animal, Receptors, Retinoic Acid, Drug Resistance, Neoplasm, Cell Line, Tumor, PPAR delta, PPAR-beta, Fatty Acid-Binding Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks